Altuviiio Children's Study Demonstrates Equivalent Outcomes

A yearlong study of the newly approved half-life extender showed no evidence of factor VIII inhibitors.

Related Keywords

Jivi Bayer ,Esperoct Novo Nordisk ,Hemlibra Roche ,Lynn Malec ,Sanofi Genzyme ,College Of Wisconsin ,Versiti Blood Research Institute In Milwaukee ,Weekly Factor ,Novo Nordisk ,Bill Sibold ,Comprehensive Center ,Versiti Blood Research Institute ,Medical College ,